Functional Dyspepsia
166
34
39
82
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Research Maturity
82 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.4%
4 terminated out of 166 trials
95.3%
+8.8% vs benchmark
26%
43 trials in Phase 3/4
5%
4 of 82 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 82 completed trials
Clinical Trials (166)
Interactive Effects of Early-Life Stress, Diet, and Metabolism on Gastrointestinal Dysfunction With Neuropsychiatric Symptoms
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
Mechanism of FODMAP Restriction on FGID Patients
Probiotics in Functional Dyspepsia
A Pilot Investigation of Pain Reprocessing Therapy for Functional Dyspepsia
Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
Identifying Multidimensional Signatures of Gastric Interoception in Functional Dyspepsia
The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies
Cerebral Cortical Influences on Autonomic Function
Liver Steatosis and Fibrosis in Non-Celiac Wheat Sensitivity Patients: a Prospective Study
A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional Dyspepsia
Brain-Gut Yoga for Functional Dyspepsia and Gastroparesis (FD-GP)
A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia
Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome
Tradipitant for Functional Dyspepsia
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
Prevalence of Functional Dyspepsia in a Rural Community of Bangladesh : A Cross Sectional Study
Small Intestinal Bacterial Overgrowth: A Prospective Registry
Enabling Microbiomics- Driven Personalized Nutrition
Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects